Clinical Trial Update: Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for neoadjuvant sequential administration of two gemcitabine-based combinations in operable breast cancer; study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-07-22